Bruker has announced the planned discontinuation of the IsoSpark and IsoLight platforms. Customers with questions about transition options and last-time-buy opportunities should contact their Bruker sales representative.
In this Webinar we discuss:
Targeting non-small cell lung cancer using a cell carrier system to deliver an oncolytic & immunostimulatory adenovirus
Efficacy of oncolytic virotherapy in 3D cell culture and in vivo
Assessing T cell functionality with single-cell proteomics